These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15751627)

  • 1. [Pain management for cancer patients with critical pathway on computer].
    Hori N; Konishi T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):167-71. PubMed ID: 15751627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer pain management using opioid together with NSAIDs at Sakai Kinki University Hospital].
    Iwasaki H; Hirose Y; Morita T; Matsuoka H; Otsuka M
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1391-3. PubMed ID: 19692787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
    Koizumi W; Toma H; Watanabe K; Katayama K; Kawahara M; Matsui K; Takiuchi H; Yoshino K; Araki N; Kodama K; Kimura H; Kono I; Hasegawa H; Hatanaka K; Hiraga K; Takeda F
    Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.
    Suzuki T; Morishita M; Ito E; Matsuura M; Tanaka R; Saito T
    Am J Ther; 2008; 15(1):31-5. PubMed ID: 18223351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oxycodone in polytrauma patients: the "Gemelli" experience.
    Franceschi F; Marini M; Ursella S; Carbone L; Candelli M; Pignataro G; Gabrielli M; Santarelli L; Ojetti V; Giupponi B; Fiore V; Barbaro F; De Marco G; Buccelletti F; Mancini F; Roccarina D; Gigante G; Gasbarrini A; Gasbarrini G; Silveri NG
    Eur Rev Med Pharmacol Sci; 2008; 12(2):123-6. PubMed ID: 18575163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.
    Rodriguez RF; Castillo JM; Del Pilar Castillo M; Nuñez PD; Rodriguez MF; Restrepo JM; Rodriguez JM; Ortiz Y; Angel AM
    Clin Ther; 2007 Apr; 29(4):581-7. PubMed ID: 17617281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
    Yu SY;
    Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute, chronic, and cancer pain. Clinical management.
    Burton AW
    Methods Mol Med; 2003; 84():267-83. PubMed ID: 12703331
    [No Abstract]   [Full Text] [Related]  

  • 16. [Basic studies on cancer pain control].
    Yajima Y; Narita M; Ozaki M; Niikura K; Suzuki T
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1377-83. PubMed ID: 16227733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids for metastatic bone pain.
    Hara S
    Oncology; 2008; 74 Suppl 1():52-4. PubMed ID: 18758198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy comparison between morphine sulfate controlled-released tablet and morphine hydrochloride sustained-released tablet in treating cancer pain].
    Yao WX; Zhou H; Wang LY; Wei Y; Liu XY
    Ai Zheng; 2007 Dec; 26(12):1357-9. PubMed ID: 18076801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe postherpetic neuralgia pain.
    Fan BF;
    Oncology; 2008; 74 Suppl 1():66-71. PubMed ID: 18758201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.